Publication | Open Access
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma
35
Citations
23
References
2016
Year
Intratumoural and peritumoural DT01 in combination with radiotherapy is safe and pharmacokinetic analyses suggest a systemic passage of DT01.
| Year | Citations | |
|---|---|---|
Page 1
Page 1